Rise in incidence of cancer, increase in number of oncology drug approvals, and surge in safety concerns of healthcare workers drive the growth of the global closed system transfer devices market
PORTLAND, Ore., Nov. 22, 2021 /PRNewswire/ -- Allied Market Research published a report, titled, "Closed System Transfer Devices Market by Type (Membrane to Membrane and Needleless), By Technology (Diaphragm Based, Compartmentalized, and Filtration), and End User (Hospitals & Clinics, Oncology Centers, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030". According to the report, the global closed system transfer devices industry generated $823.58 million in 2020, and is anticipated to generate $3.27 billion by 2030, witnessing a CAGR of 15.4% from 2021 to 2030.
Rise in incidence of cancer, increase in number of oncology drug approvals, and surge in safety concerns of healthcare workers drive the growth of the global closed system transfer devices market. However, high cost of implementation and lack of awareness hinder the market growth. On the other hand, increase in application of CSTDs in other therapeutic areas coupled with rise in safe usage initiative present new opportunities in the coming years.
The outbreak of the Covid-19 pandemic had a negative impact on the global closed system transfer devices market.
As most of the clinics and hospitals across the globe were restructured to increase the hospital capacity for patients diagnosed with COVID-19, the demand for closed system transfer devices decreased.
The non-essential procedures took a potential backlog due to rapid rise of COVID-19 cases, which in turn, hampered the market.
The membrane to membranesegment to maintain its leadership status throughout the forecast period
Based on type, the membrane to membrane segment held the highest market share in 2020, accounting for more than two-thirds of the global closed system transfer devices market, and is estimated to maintain its leadership status throughout the forecast period. Moreover, the same segment is projected to manifest the highest CAGR of 16.2% from 2021 to 2030. This is due to their ease of operation, low risk of contamination, and increase in safety of healthcare workers due to double membrane system. The report also analyzes the needleless segment.
The hospitals & clinicssheetsegment to maintain its lead position during the forecast period
Based on end user, the hospitals & clinics segment accounted for the largest share in 2020, contributing to around three-fourths of the global closed system transfer devices market, and is projected to maintain its lead position during the forecast period. Moreover, the same segment is expected to portray the largest CAGR of 16.0% from 2021 to 2030. This is due to rise in cancer cases leading to chemotherapy procedures. The report also discusses the oncology centers segment.
North America to maintain its dominance by 2030
Based on region, North America held the highest market share in terms of revenue 2020, accounting for more than one-third of the global closed system transfer devices market. This is due to rise in cancer cases and presence of key players across North America. However, the Asia-Pacific region is expected to witness the fastest CAGR of 17.7% from 2021 to 2030, owing to increase in prevalence of cancer, surge in R-&D activities for new oncology drugs, and rise in awareness for safety of the healthcare personnel.
Leading Market Players:-
B. Braun Holding GmbH & Co. KG
Becton, Dickinson and Company
FIMI Opportunity Funds (Simplivia Healthcare)
JCB Co Ltd. (JMS Co Ltd.)
Avenue Basic Plan | Library Access | 1 Year Subscription |
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
"We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market."
Trending Reports in Healthcare Industry (Book Now with 10% Discount):
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.